 |
Abdominal Aortic Aneurysm |
Adult |
Aug 2017 |
2020/21 |
 |
Systematic population screening programme recommended |
|
| |
Alcohol Misuse |
Adult |
Mar 2017 |
2019/20 |
 |
Systematic population screening programme not recommended |
 |
| |
Amino acid metabolism disorders |
Newborn |
Mar 2015 |
2017/18 |
|
Systematic population screening programme not recommended |
|
| |
Anaemia |
Antenatal |
Jul 2006 |
2012/13 |
|
Systematic population screening programme not recommended, clinical practice guidelines covered by NICE |
|
| |
Asymptomatic bacteriuria |
Antenatal |
Mar 2017 |
2019/20 |
|
Systematic population screening programme not recommended, clinical practice guidelines covered by NICE |
|
| |
Atrial Fibrillation |
Adult |
Aug 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Autism |
Child |
Nov 2012 |
2015/16 |
|
Systematic population screening programme not recommended |
|
| |
Bacterial vaginosis |
Antenatal |
Jan 2015 |
2017/18 |
|
Systematic population screening programme not recommended |
|
| |
Biliary atresia |
Newborn |
Dec 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
Biotinidase deficiency |
Newborn |
Apr 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Bladder Cancer |
Adult |
Jun 2015 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Blood group & RhD status and red cell alloantibodies |
Antenatal |
Jul 2006 |
2012/13 |
|
Systematic population screening programme not recommended |
|
| |
Bowel Cancer |
Adult |
Aug 2018 |
2021/22 |
|
Systematic population screening programme recommended |
|
| |
Breast Cancer |
Adult |
Apr 2019 |
2022/23 |
|
Systematic population screening programme recommended |
|
| |
Cervical Cancer |
Adult |
Apr 2019 |
2022/23 |
|
Systematic population screening programme recommended |
|
| |
Chlamydia (adult) |
Adult |
Jul 2006 |
2009/10 |
|
Systematic population screening programme not recommended |
|
| |
Chlamydia (pregnancy) |
Antenatal |
Apr 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Coeliac Disease |
Adult |
May 2014 |
2017/18 |
|
Systematic population screening programme not recommended |
|
| |
Congenital adrenal hyperplasia |
Newborn |
Jan 2016 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Congenital cataracts |
Newborn |
Jul 2006 |
n/a |
|
Systematic population screening programme recommended |
|
| |
Congenital heart disease |
Newborn |
May 2014 |
2017/18 |
|
Systematic population screening programme recommended |
|
| |
Congenital hypothyroidism |
Newborn |
Feb 2009 |
2012/13 |
|
Systematic population screening programme recommended |
|
| |
COPD |
Adult |
Aug 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Cryptorchidism |
Newborn |
n/a |
n/a |
|
Systematic population screening programme recommended |
|
| |
Cystic fibrosis (newborn) |
Newborn |
Jul 2006 |
n/a |
|
Systematic population screening programme recommended |
|
| |
Cystic fibrosis (pregnancy) |
Antenatal |
Aug 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Cytomegalovirus |
Antenatal |
Dec 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
Dementia |
Adult |
Apr 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Dental Disease |
Child |
Dec 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Depression |
Adult |
Jun 2015 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Development & Behaviour |
Child |
May 2005 |
2013/14 |
|
Systematic population screening programme not recommended |
|
| |
Developmental dislocation of the hip |
Newborn |
Jul 2006 |
n/a |
|
Systematic population screening programme recommended |
|
| |
Diabetes |
Adult |
Dec 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Diabetic Retinopathy |
Adult |
Jan 2016 |
2018/19 |
|
Systematic population screening programme recommended |
|
| |
Domestic Violence |
Adult |
Dec 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Domestic violence (pregnancy) |
Antenatal |
Dec 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Down's syndrome |
Antenatal |
Jan 2016 |
2018/19 |
|
Systematic population screening programme recommended |
|
| |
Duchenne muscular dystrophy |
Newborn |
Nov 2016 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Familial Hypercholesterolaemia (adult) |
Adult |
Dec 2011 |
2014/15 |
|
Systematic population screening programme not recommended |
|
| |
Familial Hypercholesterolaemia (child) |
Child |
Mar 2016 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Fatty-acid oxidation disorders |
Newborn |
Jun 2015 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Fetal anomalies |
Antenatal |
Jan 2016 |
2018/19 |
|
Systematic population screening programme recommended |
|
| |
FMAIT |
Antenatal and newborn |
Mar 2017 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Fragile X |
Antenatal |
Apr 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
GA1 |
Newborn |
May 2014 |
2017/18 |
|
Systematic population screening programme recommended |
|
| |
Galactosaemia |
Newborn |
Jun 2015 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Gaucher disease |
Newborn |
Apr 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Genital Herpes |
Antenatal |
Oct 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Gestational diabetes |
Antenatal |
Jul 2006 |
2013/14 |
|
Systematic population screening programme not recommended, clinical practice guidelines covered by NICE |
|
| |
Glaucoma |
Adult |
Dec 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Group B Streptococcus |
Antenatal |
Mar 2017 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Growth |
Child |
Jul 2006 |
2012/13 |
|
Systematic population screening programme recommended |
|
| |
Haemochromatosis |
Adult |
Nov 2016 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
HCU |
Newborn |
May 2014 |
2017/18 |
|
Systematic population screening programme recommended |
|
| |
Hearing (child) |
Child |
Apr 2019 |
2022/23 |
|
Systematic population screening programme recommended |
|
| |
Hearing (newborn) |
Newborn |
Jul 2006 |
n/a |
|
Systematic population screening programme recommended |
|
| |
Hearing Loss (adult) |
Adult |
Jan 2016 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Hepatitis B |
Antenatal |
Apr 2018 |
2021/22 |
|
Systematic population screening programme recommended |
|
| |
Hepatitis B and C among ethnic minorities |
Adult |
Apr 2011 |
2014/15 |
|
Systematic population screening programme not recommended |
|
| |
Hepatitis C (pregnancy) |
Antenatal |
Oct 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
HTLV |
Antenatal |
Dec 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
Human immunodeficiency virus |
Antenatal |
Apr 2018 |
2021/22 |
|
Systematic population screening programme recommended |
|
| |
Hypertension (adult) |
Adult |
Jul 2006 |
2013/14 |
|
Systematic population screening programme not recommended, risk management guidance covered by UK NSC |
|
| |
Hypertension (child) |
Child |
Oct 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Iron Deficiency Anaemia |
Child |
Dec 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
IVA |
Newborn |
May 2014 |
2017/18 |
|
Systematic population screening programme recommended |
|
| |
Kernicterus |
Newborn |
Aug 2016 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Kidney disease |
Adult |
Apr 2011 |
2014/15 |
|
Systematic population screening programme not recommended |
|
| |
LCHADD |
Newborn |
Aug 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Lead Poisoning |
Child |
Apr 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Lung cancer |
Adult |
Jul 2006 |
2015/16 |
|
Systematic population screening programme not recommended |
|
| |
MCADD |
Newborn |
Feb 2007 |
2015/16 |
|
Systematic population screening programme recommended |
|
| |
MPS1 |
Newborn |
Jan 2016 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
MSUD |
Newborn |
May 2014 |
2017/18 |
|
Systematic population screening programme recommended |
|
| |
Neural tube defect |
Antenatal |
Jul 2006 |
n/a |
|
Systematic population screening programme recommended |
|
| |
Neuroblastoma |
Child |
Jan 2016 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Obesity |
Child |
Feb 2007 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Oral Cancer |
Adult |
Jan 2016 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Organic acid oxidation disorders |
Newborn |
Mar 2016 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Osteoporosis |
Adult |
Dec 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Ovarian cancer |
Adult |
Jul 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
Parvovirus |
Antenatal |
Aug 2019 |
2022/23 |
|
Systematic population screening programme not recommended, clinical practice guidelines covered by NICE |
|
| |
PKU |
Newborn |
Jul 2006 |
n/a |
|
Systematic population screening programme recommended |
|
| |
Placenta praevia |
Antenatal |
Dec 2013 |
2016/17 |
|
Systematic population screening programme not recommended,
clinical practice guidelines covered by NICE |
|
| |
Postnatal depression |
Antenatal |
Apr 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Pre-eclampsia |
Antenatal |
Dec 2011 |
2014/15 |
|
Systematic population screening programme not recommended, clinical practice guidelines covered by NICE |
|
| |
Preterm labour |
Antenatal |
Jan 2015 |
2017/18 |
|
Systematic population screening programme not recommended |
|
| |
Prostate Cancer |
Adult |
Jan 2016 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Psychiatric illness |
Antenatal |
Apr 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Rubella susceptibility |
Antenatal |
May 2012 |
n/a |
|
Systematic population screening programme not recommended |
|
| |
SCID |
Newborn |
Dec 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
Scoliosis |
Child |
Aug 2016 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Sickle cell and Thalassaemia |
Antenatal |
Jul 2006 |
n/a |
|
Systematic population screening programme recommended |
|
| |
Sickle Cell Disease (newborn) |
Newborn |
Jul 2006 |
2014/15 |
|
Systematic population screening programme recommended |
|
| |
SMA |
Antenatal and newborn |
Oct 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Speech & Language Delay |
Child |
n/a |
2009/10 |
|
Systematic population screening programme not recommended |
|
| |
Stillbirth |
Antenatal |
Aug 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Stomach cancer |
Adult |
Mar 2016 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Sudden Cardiac Death |
Adult |
Dec 2019 |
2022/23 |
|
Systematic population screening programme not recommended |
|
| |
Syphilis |
Antenatal |
Apr 2018 |
2021/22 |
|
Systematic population screening programme recommended |
|
| |
T18 and T13 |
Antenatal |
Jan 2016 |
2018/19 |
|
Systematic population screening programme recommended |
|
| |
Thrombophilia |
All age |
Aug 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
Thyroid disease |
Adult |
Apr 2018 |
2021/22 |
|
Systematic population screening programme not recommended |
|
| |
Toxoplasmosis |
Antenatal |
Aug 2016 |
2019/20 |
|
Systematic population screening programme not recommended |
|
| |
Tyrosinaemia |
Newborn |
Jul 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
Varicella susceptibility |
Antenatal |
Mar 2016 |
2018/19 |
|
Systematic population screening programme not recommended |
|
| |
Vasa praevia |
Antenatal |
Aug 2017 |
2020/21 |
|
Systematic population screening programme not recommended |
|
| |
Vascular risk |
Adult |
Jan 2007 |
2013/14 |
|
Systematic population screening programme not recommended, risk management guidance covered by UK NSC |
|
| |
Vision Defects |
Child |
Aug 2019 |
2022/23 |
|
Systematic population screening programme recommended |
|
